
TOKYO -- When Ugur Sahin, co-founder of the German biotech company BioNTech, first picked up an article published in January in the Lancet medical journal about a mysterious virus in Wuhan, he told his wife and business partner Ozlem Tureci that he expected it to spread to Germany by April.
By March, schools and kindergartens in most German states had been shut to slow the coronavirus spread.